Quality Management System (QMS) – The New QMS Paradigm Explained - Comparing Commonalities Between FDA, EMA and Other International Regulatory Requirements
Live, Interactive Training Webinar
Available Live On-Demand
Instructor: Kim Huynh-Ba Biography>>>
Available Live On-Demand
This live training webinar will focus on the significant changes that the FDA, EMA, Japanese authorities and other countries have been driving over the last decade. All agencies have recognized we have been driving our operations to the mantra of what does the agency want? We have become an industry that is more interested in “check the box of compliance.” Now the agencies have told us what they want. They want us to be data and science driven. They want us to tell them what we will do and show them why it is the right thing to do. We are at a crossroads of taking back our industry and controlling our own destiny again.
In this live presentation, we are going to focus on the building blocks that you will need in place. Some of them are in the Guidances already while others are on the way. Some of them may be implemented in your operations but not all, I hasten to say.
ICH Q7 – GMP for Active Pharmaceutical Ingredients is the cornerstone of the concerted GMPs accepted worldwide. This is augmented by ICH Q10 – Pharmaceutical Quality Systems. This is based on ISO 9000 and includes a drive for continuous improvement (CI) which is built on science based and data driven decisions. Included is the active participation of management in driving for improvements not only to our products and processes but also our QMS. A key cornerstone of CI is an effective Corrective Action and Preventive Action (CAPA) process.
This science driven and fact based decision making cannot be successful without considering the lifecycle of the product and process. ICH Q8 (Pharmaceutical Development) and Q11 (Development and Manufacture of Drug Substances) deal with the modern approaches to development of products and processes. In order to arrive at a product that is patient focused and a process that yields the product consistently, we have to be ruthless in the development cycle and only focus on high value added work. The tools of Quality Rick Management (ICH Q9) are critical to differentiate the relevant from the irrelevant in process design. The management of the lifecycle activity is beginning to take shape with the latest ICH Q12 - Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. The concept paper is out and the first draft will follow soon.
Certain other systems are critical in this new QMS paradigm. Change control becomes a critical element of the development cycle, so the system must be fast and nimble in development versus the stolid ponderous of commercial. The internal self-inspection program that most view as a check to assure everything is in compliance can take a new role as a source for CI looking for improvements and proposing best practices they have seen elsewhere. The Annual Product Review blossoms into a CI tool, where trending and interpretation lead to improvements.
-How all of the agencies are approaching the new QMS requirements, what they expect and what they will be inspecting you for.
-How GMP and ICH Q10 are linked and how ICH Q9 ties into the new system requirements.
-How lifecycle management for products and processes and your QMS are tied together through Knowledge Management.
-How to evaluate and revamp you systems to meet the agency expectations and also streamline your operations.
-Learn what the new ICH Q12 may very well say and how you can be ahead of the game.
-Management’s increased role can aid in your long range and day to day operational efficiency.
Webinar outline and time breakdown: Time*
|10:15 AM||Log In Period|
|10:40 AM||The new QMS paradigm and what it contains,|
|ICH Q10 and its implementation,|
|Tying ICH Q9 into the operations,|
|Product Life cycle and what it entails,|
|Knowledge management – its value,|
|11:40 AM||Systems as they evolve over the life cycle,|
|Fueling the continuous improvement process,|
|Key role of an effective CAPA process – how to make it serve you,|
|Self-Inspection and APR in a new light,|
|The new ICH Q12 – Product Lifecycle,|
|12:30 PM||Live Questions & Discussion|
*Please note all times are Eastern Time (New York Time)
This live training webinar includes the following for each registered attendee:
- A copy of the presentation slides
- A certificate of participation for attendee training records
Who should attend:
The following individuals or disciplines will benefit from attending this Webinar:
- Quality Assurance Personnel
- Quality Control Personnel
- Supply Chain and Logistics Managers
- Regulatory Affairs Professionals
- Process Development Scientists and Management
- Manufacturing Management and Scientists
- Project Managers working in the CMC arena
Instructor: Peter Calcott Ph.D.
Peter H. Calcott, Ph.D. is President, Calcott Consulting which is focused on delivering solutions to pharmaceutical and biotechnology companies in the areas of corporate strategy, supply chain, quality, clinical development, regulatory affairs, corporate compliance and enterprise e-solutions. He is also an Academic Program Developer for the University of California, Berkeley’s Biotechnology and Pharmaceutics Postgraduate Programs. Prior to this he was VP at the executive team level at PDL BioPharma where he was responsible for development and implementation of Quality & Compliance strategy across the corporation… Full Bio>>>
All Pharma Webinars live training programs audio and visual are delivered via Cisco WebEx with basic system requirements of a computer with internet access and a telephone to access the audio portion of the presentations. You can choose to access the audio through your computer.
Live Training Benefits:
Live Training Benefits:
• Pharma Webinars training webinars and programs are presented exclusively as live events only.
• Designed and delivered based on e-learning best practices, Pharma Webinars' live training webinars and programs are as effective as in person training.
• Live training webinars and multi-part training programs are strictly educational based, and do not promote or endorse any products or services whatsoever.
• An interactive live Q&A and discussion period is included in each live training presentation. Questions can also be submitted to the speaker via email both prior to and following the live training webinar as a means of improving participant experience, and ensuring successful topic comprehension.
• Live presentations ensure that all live training webinars and programs are engaging and informative, allowing trainees to exchange ideas through audio conferencing and live chat during each presentation in real time. Each live training session includes a dedicated live Q&A period allowing trainees to interact directly with the instructor, with quick feedback providing them with concrete understanding of the answers and the training subject itself.
• Each Pharma Webinars live training webinar and program content is updated on regular basis to provide the latest regulatory, operational and technological trends in the international pharmaceutical arena. As regulatory expectations, guidance, or industry trends change, so does our training in order to reflect those changes as soon as the changes are released.
• Pharma Webinars' instructors are the most recognized subject matter experts in the industry who are selected based on very strict qualification criteria. They are coached on the latest e-learning speaking methods in order to make each presentation engaging, memorable and very effective.
• Each registered attendee receives an exact copy of the presentation slides and other course handouts significantly reducing the learning curve as trainees can refer back to this material in the future.
• All trainees receive a Certificate of Attendance for each live training webinar and program they attend to be kept for training records.